Asthma treatment

http://www.healasthma.com – . NEW ASTHMA INHALANT BETTER A new asthma inhalant is better at preventing attacks and lasts longer than a widely used medication, researchers said in Wednesday’s issue of the Journal of the American Medical Association. The new drug, salmeterol xinafoate, recently was approved for marketing in the United States under the brand name Serevent. The researchers compared it with albuterol, sold under various brand names including Proventil and Ventolin. … GOVERNMENT ENDS WEAPONS RESALE BY U.S. AGENCIES WASHINGTON– After allowing federal agencies to dump more than , used firearms into the civilian marketplace for more than a decade, the General Services Administration announced late Wednesday that it is halting the practice.The GSA decision came after the New York newspaper Newsday asked the agency for a list of weapons it had allowed federal departments to sell to civilian firearms dealers. GENERIC ASTHMA MEDICINE RECALLED DUE TO IMPURITY WASHINGTON — A Massachusetts generic… HEALTHY OUTLOOK STEPHEN DANIELS ALTHOUGH THE A/H N (swine) flu captured the headlines and sent throngs to local ERs, seasonal allergies and asthma have been much more common in doctors’ offices so far this season.The principle defining symptoms of all flus are cough, fever and body ache. By contrast, people with just allergies or asthma rarely have a fever or body ache, though they have a cough. Allergies most commonly produce watery, itchy and/or swollen eyes and/or nose. Asthma causes… . FD (FAIR DISCLOSURE) WIRE – Q Sepracor Earnings Conference Call – Final OPERATOR Ladies and gentlemen, welcome to Sepracor’s fourth-quarter and full-year earnings conference call. Hosting the call today from Sepracor is Mr. Adrian Adams, President and Chief Executive Officer. (Operator Instructions). It is now my pleasure to turn the floor over to your host, Mr. Adrian Adams. Sir, you begin. ADRIAN ADAMS, PRESIDENT AND CEO, SEPRACOR INC. Thank you, operator, and good morning, everyone, and thank you for joining us for our… . Daily Camera, The (Boulder, CO) – Despite the wheezing it can cause, Colorado’s cold, dry winter air is impossible to avoid for asthmatics — especially if it’s your job to be outdoors year-round. Fortunately, the air has to be pretty cold before it bothers Ken Hill, a hydrologist for the United States Geological Survey. Hill works outdoors two to four days a week, often skiing (with a heavy pack) in to high weather stations in Rocky Mountain National Park. It’s the sub-zero temps he has Despite the wheezing it can cause, Colorado’s cold, dry winter air is impossible to avoid for asthmatics — especially if it’s your job to be outdoors year-round. Fortunately, the air has to be pretty cold before it bothers Ken Hill, a hydrologist for the United States Geological Survey. Hill works outdoors two to four days a week, often skiing (with a heavy pack) in to high weather stations in Rocky Mountain National Park. It’s the sub-zero temps he has… . Chemical Business NewsBase BT Catalyst (United Kingdom) – Chemical Business Newsbase – BT Catalyst Next Safety to sell inhaler. Next Safety, of the Ashe County community of Jefferson, in northwestern North Carolina, has opened an auction bidding process to run through Feb to sell its proprietary air-based drug-delivery platform. Next Safety says its technology differs from other inhalant devices because it uses air to deliver drugs such as nicotine and asthma medications including albuterol and the components of Advair, fluticasone propionate and salmeterol xinofoate, timed to the user’s inhalation…. . (USA) – Breathing Trouble Question In a dramatic move, an FDA advisory panel has recommended the elimination or restriction of a group of asthma medicines-long-acting beta-agonists-that many patients with severe asthma have come to depend on. While “controller” drugs like steroids stop the inflammation that leads to asthma attacks, patients use short-acting (”rescue”) beta-agonists like albuterol for immediate relief of the tightness and wheezing of acute attacks. For… High Growth Reported for the World Pharmaceuticals Market Brief Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. World Pharmaceuticals Market Brief http://www.reportlinker.com/p /World-Pharmaceuticals-Market-Brief.html The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report provides a bird�s eye view of the pharmaceutical industry,… KFSM (Fort Smith-Fayetteville-Springdale-Rogers, AR) – News at Noon – TIME START I WOULDN’T FIND OUT?Daniel I DON’T KNOW WHAT YOU’RE TALKING ABOUT.Colleen ABOUT AMBER.(scoffs) YOU INVITED HER TO YOUR OPENING.SO I GUESS MY INVITATION GOT LOST IN THE MAIL, RIGHT?Daniel COLLEEN, UM, I DON’T REALLY KNOW HOW TO SAY THIS, SO I’M JUST GONNA BE STRAIGHT WITH YOU AND TELL YOU.I DON’T–I DON’T KNOW WHY, BUT I… . M Presswire – Bellwether Market Watch Teva Specialty Pharmaceuticals and UCB Teaming Up… Today Bellwether Report has identified Pharmaceutical Industries Ltd. (NASDAQ TEVA), a company that our analysts will be tracking over the ensuing weeks. They recently came out with a significant corporate development on Wednesday, causing a short term market correction. For a full report on the below mentioned company, and many more, feel free to visit www.bellwetherreport.com for a free day no obligation trial. Teva Pharmaceutical… –